Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 136

1.

Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland.

Strus M, Drzewiecki A, Chmielarczyk A, Tomusiak A, Romanek P, Kosowski K, Kochan P, van der Linden M, Lütticken R, Heczko PB.

Clin Microbiol Infect. 2010 Sep;16(9):1442-7. doi: 10.1111/j.1469-0691.2009.03139.x.

2.

Rapid detection of Streptococcus agalactiae from swabs by peptide nucleic acid fluorescence in situ hybridization.

Peltroche-Llacsahuanga H, Fiandaca MJ, von Oy S, Lütticken R, Haase G.

J Med Microbiol. 2010 Feb;59(Pt 2):179-84. doi: 10.1099/jmm.0.013995-0. Epub 2009 Oct 15.

PMID:
19833782
3.

Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens.

Peltroche-Llacsahuanga H, Top J, Weber-Heynemann J, Lütticken R, Haase G.

J Clin Microbiol. 2009 Dec;47(12):4113-6. doi: 10.1128/JCM.00882-09. Epub 2009 Oct 7.

4.

Epidemiology of severe Streptococcus pyogenes disease in Europe.

Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C; Strep-EURO Study Group, Jasir A.

J Clin Microbiol. 2008 Jul;46(7):2359-67. doi: 10.1128/JCM.00422-08. Epub 2008 May 7.

5.

Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.

Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW.

Infection. 2008 Feb;36(1):31-5. doi: 10.1007/s15010-007-6316-4. Epub 2008 Jan 29.

PMID:
18231721
6.

Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.

Wahl RU, Lütticken R, Stanzel S, van der Linden M, Reinert RR.

Clin Microbiol Infect. 2007 Dec;13(12):1173-8. Epub 2007 Sep 10.

7.

A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.

Lintges M, Arlt S, Uciechowski P, Plümäkers B, Reinert RR, Al-Lahham A, Lütticken R, Rink L.

Int J Med Microbiol. 2007 Oct;297(6):471-8. Epub 2007 May 3.

PMID:
17481952
8.

Epidemiology of Streptococcus agalactiae colonization in Germany.

Brimil N, Barthell E, Heindrichs U, Kuhn M, Lütticken R, Spellerberg B.

Int J Med Microbiol. 2006 Feb;296(1):39-44. Epub 2005 Dec 19.

PMID:
16361113
9.

Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.

Brandt CM, Schweizer KG, Holland R, Lütticken R, Freyaldenhoven BS.

Int J Med Microbiol. 2005 Dec;295(8):539-46. Epub 2005 Oct 20.

PMID:
16325550
10.

Enterococcus raffinosus infection in an immunosuppressed patient: case report and review of the literature.

Freyaldenhoven BS, Schlieper G, Lütticken R, Reinert RR.

J Infect. 2005 Oct;51(3):e121-4. Epub 2004 Nov 21. Review.

PMID:
16230189
11.

Evaluation of postdischarge surveillance of surgical site infections after total hip and knee arthroplasty.

Huenger F, Schmachtenberg A, Haefner H, Zolldann D, Nowicki K, Wirtz DC, Bläsius K, Lütticken R, Lemmen SW.

Am J Infect Control. 2005 Oct;33(8):455-62.

PMID:
16216659
12.

Surveillance of nosocomial infections in a neurologic intensive care unit.

Zolldann D, Spitzer C, Häfner H, Waitschies B, Klein W, Sohr D, Block F, Lütticken R, Lemmen SW.

Infect Control Hosp Epidemiol. 2005 Aug;26(8):726-31.

PMID:
16156331
13.

Periodic surveillance of nosocomial infections in a neurosurgery intensive care unit.

Zolldann D, Thiex R, Häfner H, Waitschies B, Lütticken R, Lemmen SW.

Infection. 2005 Jun;33(3):115-21.

PMID:
15940411
14.

Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity.

Wagenvoort JH, Penders RJ, Davies BI, Lütticken R.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):65-7. Review. No abstract available.

PMID:
15599644
16.

Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000.

Reinert RR, Lütticken R, Reinert S, Al-Lahham A, Lemmen S.

Chemotherapy. 2004 Oct;50(4):184-9. Epub 2004 Sep 3.

PMID:
15347911
17.

Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.

Reinert RR, Franken C, van der Linden M, Lütticken R, Cil M, Al-Lahham A.

Int J Antimicrob Agents. 2004 Jul;24(1):43-7.

PMID:
15225860
18.

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Reinert RR, Lütticken R, Al-Lahham A.

Clin Microbiol Infect. 2004 Jul;10(7):659-62.

19.

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.

Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C.

Circulation. 2004 Jun 1;109(21):2560-5. Epub 2004 May 3.

PMID:
15123521
20.
21.

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Reinert RR, Lütticken R, Sutcliffe JA, Tait-Kamradt A, Cil MY, Schorn HM, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2004 Apr;48(4):1369-73.

22.

Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment.

Lemmen SW, Häfner H, Zolldann D, Stanzel S, Lütticken R.

J Hosp Infect. 2004 Mar;56(3):191-7.

PMID:
15003666
23.

Streptococcus pyogenes meningitis complicating varicella in a 3-month-old child.

Brandt CM, Kitz R, Lütticken R, Brade V.

Scand J Infect Dis. 2003;35(11-12):876-8.

PMID:
14723366
24.

Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing.

Reinert RR, Muckel S, Al-Lahham A, Spratt BG, Brueggemann AB, Hakenbeck R, Lütticken R.

J Med Microbiol. 2003 Nov;52(Pt 11):981-7.

PMID:
14532343
25.

Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested.

Schmidt S, Haase G, Csomor E, Lütticken R, Peltroche-Llacsahuanga H.

J Biomed Mater Res A. 2003 Sep 1;66(3):491-9.

PMID:
12918031
26.

Assessment of a selective surveillance method for detecting nosocomial infections in patients in the intensive care department.

Zolldann D, Haefner H, Poetter C, Buzello S, Sohr D, Luetticken R, Lemmen SW.

Am J Infect Control. 2003 Aug;31(5):261-5. Erratum in: Am J Infect Control. 2003 Oct;31(6):386. Sohr David [corrected to Sohr Dorit].

PMID:
12888760
27.

Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.

Reinert RR, Wild A, Appelbaum P, Lütticken R, Cil MY, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Jul;47(7):2319-22.

28.
29.

drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolates.

Brandt CM, Haase G, Spellerberg B, Holland R, Lütticken R.

J Clin Microbiol. 2003 Apr;41(4):1794-7.

30.

Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Reinert RR, Lütticken R, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Feb;47(2):489-93.

31.

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.

Reinert RR, Al-Lahham A, Lütticken R, Boos M, Schmitz FJ.

J Antimicrob Chemother. 2002 Jun;49(6):1015-8.

PMID:
12039895
32.

rgf encodes a novel two-component signal transduction system of Streptococcus agalactiae.

Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Lütticken R.

Infect Immun. 2002 May;70(5):2434-40.

33.

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lütticken R.

J Antimicrob Chemother. 2002 Jan;49(1):61-8.

PMID:
11751768
34.
35.

Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb.

Franken C, Haase G, Brandt C, Weber-Heynemann J, Martin S, Lämmler C, Podbielski A, Lütticken R, Spellerberg B.

Mol Microbiol. 2001 Aug;41(4):925-35.

37.

Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.

Brandt CM, Honscha M, Truong ND, Holland R, Hövener B, Bryskier A, Lütticken R, Reinert RR.

Microb Drug Resist. 2001 Summer;7(2):165-70.

PMID:
11442342
38.

Typing of Streptococcus pyogenes strains isolated from throat infections in the region of Aachen, Germany.

Brandt CM, Spellerberg B, Honscha M, Truong ND, Hoevener B, Lütticken R.

Infection. 2001 May-Jun;29(3):163-5.

PMID:
11440388
39.

Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.

Reinert RR, von Eiff C, Kresken M, Brauers J, Hafner D, Al-Lahham A, Schorn H, Lütticken R, Peters G; Multicenter Study on Antibiotic Resistance in Staphylococci and other Gram-positive Cocci (MARS) Study Group.

J Clin Microbiol. 2001 May;39(5):1928-31.

40.

Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units.

Lemmen SW, Zolldann D, Gastmeier P, Lütticken R.

Am J Infect Control. 2001 Apr;29(2):89-93.

PMID:
11287875
41.

Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome.

Müller N, Kroll B, Schwarz MJ, Riedel M, Straube A, Lütticken R, Reinert RR, Reineke T, Kühnemund O.

Psychiatry Res. 2001 Mar 25;101(2):187-93.

PMID:
11286821
42.

Comparison of two sampling methods for the detection of gram-positive and gram-negative bacteria in the environment: moistened swabs versus Rodac plates.

Lemmen SW, Häfner H, Zolldann D, Amedick G, Lütticken R.

Int J Hyg Environ Health. 2001 Mar;203(3):245-8.

PMID:
11279821
43.

Assessment of acid production by various human oral micro-organisms when palatinose or leucrose is utilized.

Peltroche-Llacsahuanga H, Hauk CJ, Kock R, Lampert F, Lütticken R, Haase G.

J Dent Res. 2001 Jan;80(1):378-84.

PMID:
11269732
44.
45.

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.

Lemmen S, Al-Lahham A, Lütticken R, Reinert RR.

Chemotherapy. 2001 Mar-Apr;47(2):104-9.

PMID:
11173811
46.

Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure: special reference to prtF1 and sic / drs.

Brandt CM, Allerberger F, Spellerberg B, Holland R, Lütticken R, Haase G.

J Infect Dis. 2001 Feb 15;183(4):670-4. Epub 2001 Jan 24.

PMID:
11170997
47.

Comparison of serum bactericidal activity of ceftazidime, ciprofloxacin and meropenem against Stenotrophomonas maltophilia.

Lemmen SW, Häfner H, Reinert RR, Zolldann D, Kümmerer K, Lütticken R.

J Antimicrob Chemother. 2001 Jan;47(1):118-20. No abstract available.

PMID:
11152445
48.
49.

Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens.

Lemmen SW, Häfner H, Kotterik S, Lütticken R, Töpper R.

Infection. 2000 Nov-Dec;28(6):384-7.

PMID:
11139159
50.

In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany.

Reinert RR, Al-Lahham A, Lemmen S, Lütticken R.

J Antimicrob Chemother. 2000 Nov;46(5):854-6. No abstract available.

PMID:
11062219
51.

Differentiation between Candida dubliniensis and Candida albicans by fatty acid methyl ester analysis using gas-liquid chromatography.

Peltroche-Llacsahuanga H, Schmidt S, Seibold M, Lütticken R, Haase G.

J Clin Microbiol. 2000 Oct;38(10):3696-704.

52.

Phagocytosis, oxidative burst, and killing of Candida dubliniensis and Candida albicans by human neutrophils.

Peltroche-Llacsahuanga H, Schnitzler N, Schmidt S, Tintelnot K, Lütticken R, Haase G.

FEMS Microbiol Lett. 2000 Oct 1;191(1):151-5.

53.

The cyl genes of Streptococcus agalactiae are involved in the production of pigment.

Spellerberg B, Martin S, Brandt C, Lütticken R.

FEMS Microbiol Lett. 2000 Jul 15;188(2):125-8.

54.

Streptococcal toxic shock syndrome in two patients infected by a colonized surgeon.

Rutishauser J, Funke G, Lütticken R, Ruef C.

Infection. 1999;27(4-5):259-60.

PMID:
10885838
55.

Investigation of infectious organisms causing pericoronitis of the mandibular third molar.

Peltroche-Llacsahuanga H, Reichhart E, Schmitt W, Lütticken R, Haase G.

J Oral Maxillofac Surg. 2000 Jun;58(6):611-6.

PMID:
10847281
56.

Novel microtiter plate format for testing germ tube formation and proposal of a cost-effective scheme for yeast identification in a clinical laboratory.

Peltroche-Llacsahuanga H, Jenster A, Lütticken R, Haase G.

Diagn Microbiol Infect Dis. 1999 Nov;35(3):197-204.

PMID:
10626129
57.

Identification of a novel insertion sequence element in Streptococcus agalactiae. bspeller@imib.rwth-aachen.de.

Spellerberg B, Martin S, Franken C, Berner R, Lütticken R.

Gene. 2000 Jan 4;241(1):51-6.

PMID:
10607898
58.

Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Brandt CM, Haase G, Schnitzler N, Zbinden R, Lütticken R.

J Clin Microbiol. 1999 Dec;37(12):4194-7.

59.

A new technique for quantitative bacterial assessment on burn wounds by modified dermabrasion.

Pallua N, Fuchs PC, Hafemann B, Völpel U, Noah M, Lütticken R.

J Hosp Infect. 1999 Aug;42(4):329-37.

PMID:
10467547
60.

A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.

Reinert RR, Lütticken R, Lemperle M, Bryskier A.

J Antimicrob Chemother. 1999 Jun;43 Suppl C:5-8.

PMID:
10404330
61.

Temporally overlapping nosocomial outbreaks of Serratia marcescens infections: an unexpected result revealed by pulsed-field gel electrophoresis.

Peltroche-Llacsahuanga H, Lütticken R, Haase G.

Infect Control Hosp Epidemiol. 1999 Jun;20(6):387-8. No abstract available.

PMID:
10395136
62.

Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition.

Spellerberg B, Pohl B, Haase G, Martin S, Weber-Heynemann J, Lütticken R.

J Bacteriol. 1999 May;181(10):3212-9.

63.

Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany.

Reinert RR, Conrads G, Schlaeger JJ, Werner G, Witte W, Lütticken R, Klare I.

J Clin Microbiol. 1999 May;37(5):1638-41.

64.

Simultaneous detection of Bacteroides forsythus and Prevotella intermedia by 16S rRNA gene-directed multiplex PCR.

Conrads G, Flemmig TF, Seyfarth I, Lampert F, Lütticken R.

J Clin Microbiol. 1999 May;37(5):1621-4.

65.

Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.

Reinert RR, Schlaeger JJ, Lütticken R.

J Antimicrob Chemother. 1998 Dec;42(6):803-6.

PMID:
10052905
66.

A co-stimulatory signal through ICAM-beta2 integrin-binding potentiates neutrophil phagocytosis.

Schnitzler N, Haase G, Podbielski A, Lütticken R, Schweizer KG.

Nat Med. 1999 Feb;5(2):231-5.

PMID:
9930874
67.

Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin.

Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Schnitzler N, Lütticken R, Podbielski A.

Infect Immun. 1999 Feb;67(2):871-8.

68.

Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils.

Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Zündorf J, Lütticken R, Haase G.

Infect Immun. 1999 Jan;67(1):94-101.

69.

Rapid identification of Candida glabrata by using a dipstick to detect trehalase-generated glucose.

Peltroche-Llacsahuanga H, Schnitzler N, Lütticken R, Haase G.

J Clin Microbiol. 1999 Jan;37(1):202-5.

70.

In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.

Reinert RR, Kresken M, Mechery V, Lemperle M, Lütticken R.

Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):662-5.

PMID:
9832271
71.

[Methicillin-resistant Staphylococcus aureus (MRSA)--clinical implications].

Peltroche-Llacsahuanga H, Haase G, Lütticken R.

Chirurg. 1998 Aug;69(8):801-5. German.

PMID:
9782395
72.

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

Reinert RR, Bryskier A, Lütticken R.

Antimicrob Agents Chemother. 1998 Jun;42(6):1509-11.

73.

Estimation of type-specific anti-streptococcal M-protein antibodies with biotinylated peptides in human sera.

Kühnemund O, Schumacher F, Casaretto M, Holm SE, Lütticken R.

APMIS. 1998 Feb;106(2):288-92.

PMID:
9531961
74.

Isolation of Staphylococcus caprae from blood cultures of a neonate with congenital heart disease.

Spellerberg B, Steidel K, Lütticken R, Haase G.

Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):61-2. No abstract available.

PMID:
9512188
75.
76.

Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.

Petrasch S, Kühnemund O, Reinacher A, Uppenkamp M, Reinert R, Schmiegel W, Lütticken R, Brittinger G.

Clin Diagn Lab Immunol. 1997 Nov;4(6):635-8.

77.

Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996.

Reinert RR, Kaufhold A, Schlaeger JJ, Mechery V, Lütticken R.

Pediatr Infect Dis J. 1997 Feb;16(2):244-5. No abstract available.

PMID:
9041608
78.

Activation of granulocytes by phorbol-12-myristate-14-acetate (PMA) enhances phagocytosis of Streptococcus pyogenes.

Schnitzler N, Schweizer K, Podbielski A, Haase G, Spellerberg B, Holland R, Lütticken R.

Adv Exp Med Biol. 1997;418:897-902. No abstract available.

PMID:
9331794
79.

Immune response to the 23-valent pneumococcal polysaccharide vaccine in lymphoma patients and patients with chronic renal diseases.

Kühnemund O, Stütz A, Fuchshuber A, Querfeld U, Petrasch S, Reinert RR, Lütticken R.

Adv Exp Med Biol. 1997;418:837-9. No abstract available.

PMID:
9331783
80.

Human isolates of large colony-forming beta hemolytic group G streptococci form a distinct clade upon 16S rRNA gene analysis.

Schnitzler N, Haase G, Podbielski A, Kaufhold A, Lämmler C, Lütticken R.

Adv Exp Med Biol. 1997;418:363-5. No abstract available.

PMID:
9331671
81.

Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS).

Podbielski A, Spellerberg B, Woischnik M, Pohl B, Lütticken R.

Gene. 1996 Oct 24;177(1-2):137-47.

PMID:
8921859
82.

PCR reaction and dot-blot hybridization to monitor the distribution of oral pathogens within plaque samples of periodontally healthy individuals.

Conrads G, Mutters R, Fischer J, Brauner A, Lütticken R, Lampert F.

J Periodontol. 1996 Oct;67(10):994-1003.

PMID:
8910839
83.

Staphylococcal scalded skin syndrome in an immunocompromised adult.

Roeb E, Schönfelder T, Matern S, Sieberth HG, Lenz W, Lütticken R, Reinert RR.

Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):499-503.

PMID:
8839645
84.

Pneumococcal vaccine in children and young adults with chronic renal disease.

Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U.

Nephrol Dial Transplant. 1996 Mar;11(3):468-73.

PMID:
8671817
85.

Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994.

Reinert RR, Queck A, Kaufhold A, Kresken M, Lütticken R.

Clin Infect Dis. 1995 Dec;21(6):1398-401.

PMID:
8749622
86.

Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient.

Reinert RR, Schnitzler N, Haase G, Lütticken R, Fabry U, Schaal KP, Funke G.

Eur J Clin Microbiol Infect Dis. 1995 Dec;14(12):1082-5.

PMID:
8681984
87.

Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients.

Reinert RR, Kaufhold A, Kühnemund O, Lütticken R.

Zentralbl Bakteriol. 1994 Nov;281(4):481-90.

PMID:
7727895
88.

Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor.

Podbielski A, Blankenstein O, Lütticken R.

Med Microbiol Immunol. 1994 Nov;183(5):239-56.

PMID:
7715536
89.

Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany.

Reinert RR, Queck A, Kaufhold A, Kresken M, Lütticken R.

Infection. 1994 Mar-Apr;22(2):113-4. No abstract available.

PMID:
8070922
90.

[Dr. Wang's tube--study of a new technique for eliminating pathogens in sperm preparation for reproductive medicine].

Riedel HH, Sander K, Lütticken R.

Zentralbl Gynakol. 1994;116(7):422-32. German.

PMID:
7941810
91.

[Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].

Reinert RR, Lütticken R, Kaufhold A.

Med Klin (Munich). 1993 Jun 15;88(6):357-61. German.

PMID:
8336662
92.

T cell activation and cytokine release in streptococcal toxic shock-like syndrome.

Nadal D, Lauener RP, Braegger CP, Kaufhold A, Simma B, Lütticken R, Seger RA.

J Pediatr. 1993 May;122(5 Pt 1):727-9.

PMID:
8496751
93.

[Infections by Streptococcus pyogenes: new aspects of diagnosis, epidemiology, clinical practice, and therapy].

Kaufhold A, Podbielski A, Kühnemund O, Lütticken R.

Immun Infekt. 1992 Dec;20(6):192-9. Review. German.

PMID:
1490724
95.

[The vir-regulon of Streptococcus pyogenes: coordinate expression of important virulence factors].

Podbielski A, Kaufhold A, Lütticken R.

Immun Infekt. 1992 Oct;20(5):161-8. Review. German.

PMID:
1452195
96.

M protein gene typing of Streptococcus pyogenes by nonradioactively labeled oligonucleotide probes.

Kaufhold A, Podbielski A, Johnson DR, Kaplan EL, Lütticken R.

J Clin Microbiol. 1992 Sep;30(9):2391-7.

97.

Establishment of a pneumococcal septicemia model in the miniature swine.

Izbicki JR, Raedler C, Ruckdeschel G, Lütticken R, Wilker DK, Siebeck M, Dornschneider G, Sklarek J, Schweiberer L, Ziegler-Heitbrock HW.

Zentralbl Veterinarmed A. 1992 Mar;39(2):152-9.

PMID:
1590038
98.

Molecular cloning and nucleotide sequence of the group B streptococcal hemolysin.

Conrads G, Podbielski A, Lütticken R.

Zentralbl Bakteriol. 1991 Jun;275(2):179-84.

PMID:
1657015
99.

[Evaluation of a rapid test for direct detection of group A streptococcal antigen in throat swabs. Study of 4 commercial test systems].

Kaufhold A, Krug E, Lütticken R, Knoop U, Bläker F.

Monatsschr Kinderheilkd. 1991 Apr;139(4):208-13. German.

PMID:
2072960
100.

[Studies on post-splenectomy infection and immune activation by muramyl peptide. A new concept in the prevention of severe infections].

Izbicki JR, Ziegler-Heitbrock HW, Lütticken R, Ruckdeschel G, Wilker DK, Schweiberer L.

Chirurg. 1991 Mar;62(3):195-200. German.

PMID:
2036895
101.

Splenectomy does not influence outcome of pneumococcal septicemia in a porcine model.

Izbicki JR, Ziegler-Heitbrock HW, Raedler C, Kastl S, Bauhuber W, Wilker DK, Lütticken R, Ruckdeschel G, Schlunck T, Anke A, et al.

J Trauma. 1991 Feb;31(2):189-95.

PMID:
1994078
102.

Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci.

Podbielski A, Melzer B, Lütticken R.

Med Microbiol Immunol. 1991;180(4):213-27.

PMID:
1784271
103.

Identification of group A type 1 streptococcal M protein gene by a non-radioactive oligonucleotide detection method.

Podbielski A, Kühnemund O, Lütticken R.

Med Microbiol Immunol. 1990;179(5):255-62.

PMID:
2082158
104.

Few-minutes tests for the identification of group A streptococci and enterococci with chromogenic substrates.

Kaufhold A, Lütticken R, Schwien U.

Zentralbl Bakteriol. 1989 Dec;272(2):191-5.

PMID:
2576626
105.

Endocarditis caused by Gemella haemolysans.

Kaufhold A, Franzen D, Lütticken R.

Infection. 1989 Nov-Dec;17(6):385-7.

PMID:
2613327
106.

The impact of splenectomy on antibody response in the porcine model.

Izbicki JR, Ziegler-Heitbrock HW, Meier M, Lütticken R, Wilker DK, Siebeck M, Scheuber HP, Schweiberer L.

J Clin Lab Immunol. 1989 Sep;30(1):13-9.

PMID:
2641789
107.

An insulin receptor in microorganisms: fact or fiction?

Dietz E, Uhlenbruck G, Lütticken R.

Naturwissenschaften. 1989 Jun;76(6):269-70. No abstract available.

PMID:
2526300
108.

Cell electrophoresis of group B streptococci: separation of types Ia, Ib/c, II, III and IV before and after neuraminidase treatment.

Uhlenbruck G, Fröml A, Lütticken R, Hannig K.

Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):28-34.

PMID:
3066075
109.

[Systemic infection caused by Streptococcus suis].

Kaufhold A, Lütticken R, Litterscheid S.

Dtsch Med Wochenschr. 1988 Oct 21;113(42):1642-3. German.

PMID:
3181015
110.

Cloning and expression of the CAMP factor of group B streptococci in Escherichia coli.

Schneewind O, Friedrich K, Lütticken R.

Infect Immun. 1988 Aug;56(8):2174-9.

111.

Vancomycin-resistant Streptococcaceae from clinical material.

Lütticken R, Kunstmann G.

Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Jan;267(3):379-82.

PMID:
3376618
112.

Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany.

Kaufhold A, Lütticken R, Henrichsen J.

Eur J Clin Microbiol. 1987 Dec;6(6):696-7. No abstract available.

PMID:
3440463
113.

Meningitis caused by Streptococcus suis: case report and review of the literature.

Lütticken R, Temme N, Hahn G, Bartelheimer EW.

Infection. 1986 Jul-Aug;14(4):181-5.

PMID:
3531022
114.

[Presence of Legionellae in water of air conditioning and water installation systems in North Rhine area].

Uerlings A, Lütticken R, Höffler U.

Offentl Gesundheitswes. 1986 Jul;48(7):325-8. German. No abstract available.

PMID:
2944044
115.

[Lectins and the organotropy of metastasis].

Uhlenbruck G, Beuth HJ, Oette K, Schotten T, Ko HL, Roszkowski K, Roszkowski W, Lütticken R, Pulverer G.

Dtsch Med Wochenschr. 1986 Jun 20;111(25):991-5. Review. German. No abstract available.

PMID:
3519150
116.

[Brucella canis infection in man].

Schoenemann J, Lütticken R, Scheibner E.

Dtsch Med Wochenschr. 1986 Jan 3;111(1):20-2. German.

PMID:
3940831
117.

[Serologic cross reactions of group B streptococci].

Uhlenbruck G, Lütticken R, Bäz K, Böhmer G.

Immun Infekt. 1985 Nov;13(6):276-82. German.

PMID:
2416673
118.
119.

Group B streptococcus type II antisera have anti-galactan specificities.

Uhlenbruck G, Lütticken R, Böhmer G, Janssen E, Pulverer G.

Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Apr;259(2):179-87.

PMID:
3925659
120.

Snake venom lectins: a new group of T- and B-cell mitogenic anti-galactans.

Helmbold W, Prokop O, Uhlenbruck G, Böhmer G, Lütticken R.

Biomed Biochim Acta. 1985;44(11-12):K91-6.

PMID:
3911952
121.

The genetics of GBS.

Lütticken R.

Antibiot Chemother (1971). 1985;35:71-82. No abstract available.

PMID:
2996419
122.

Spontaneous fascial necrosis of the upper thigh by beta-hemolytic streptococci.

Thelen E, Luetticken R, Peters G.

Arch Orthop Trauma Surg. 1979 Oct;95(1-2):23-6.

PMID:
393201
123.

[Differentiation of Klebsiella pneumoniae variatio "oxytoca" (author's transl)].

Lütticken R, Korth H, Pulverer G.

Zentralbl Bakteriol Orig A. 1979 Sep;244(4):470-3. German.

PMID:
396740
124.

Susceptibility of Staphylococcus aureus and group A, B, C, and G streptococci to free fatty acids.

Heczko PB, Lütticken R, Hryniewicz W, Neugebauer M, Pulverer G.

J Clin Microbiol. 1979 Mar;9(3):333-5.

125.

Studies on streptococci resembling Streptococcus milleri and on an associated surface-protein antigen.

Lütticken R, Wendorff U, Lütticken D, Johnson EA, Wannamaker LW.

J Med Microbiol. 1978 Nov;11(4):419-31.

PMID:
82618
126.

[Streptococcal infections and their sequelae].

Lütticken R, Schaal KP.

Internist (Berl). 1978 Mar;19(3):161-5. German. No abstract available.

PMID:
25247
127.

Typing of Group A streptococci from an urban area (Köln) in West Germany.

Lütticken R, Wendorff U, Lütticken D, Wannamaker LW.

Zentralbl Bakteriol Orig A. 1977 Feb;237(1):35-43.

PMID:
190823
128.

Comparison of three methods for grouping streptococci.

Hryniewicz W, Heczko PB, Lütticken R, Wannamaker LW.

J Clin Microbiol. 1976 Jul;4(1):28-31.

129.

[Antibody response to group A streptococcal exoenzymes (author's transl)].

Lütticken R, Wannamaker LW, Kluitmann G, Neugebauer M, Pulverer G.

Dtsch Med Wochenschr. 1976 Jun 18;101(25):958-63. German.

PMID:
776554
130.
131.

[The cultural diagnosis of Cryptococcus neoformans].

Lütticken R.

Mykosen. 1975 Apr;18(4):161-5. German. No abstract available.

PMID:
52840
132.

[Identification of group B Streptococci (Streptococcus agalactiae) by means of the "triple-test" of Wallerström and the CAMP-test (author's transl)].

Lütticken R, Fritsche D.

Zentralbl Bakteriol Orig A. 1974 Mar;226(3):298-304. German. No abstract available.

PMID:
4151796
133.

[Occurrence of neuraminidase and Acylneuraminate Lyase in NAG vibrios (author's transl)].

Müller HE, Lütticken R.

Pathol Microbiol (Basel). 1974;41(5):233-9. German. No abstract available.

PMID:
4444832
134.

[Pseudomonas maltophilia as an agent of infection in man (author's transl)].

Fritsche D, Lütticken R, Böhmer H.

Zentralbl Bakteriol Orig A. 1974;229(1):89-97. German. No abstract available.

PMID:
4155214
135.

[Occurrence of NAG vibrios (non-cholera vibrios) in West Germany].

Ko HL, Lütticken R, Pulverer G.

Dtsch Med Wochenschr. 1973 Aug;98(32):1494-9. German. No abstract available.

PMID:
4725400
136.

[Salmonella meningitis in adults: a case of Salmonella typhimurium infection].

Spieckermann D, Lütticken R, Goertz B.

Infection. 1973;1(3):178-80. German. No abstract available.

PMID:
4597101

Supplemental Content

Loading ...
Support Center